CME

CME


Latest Episodes

Managing Immune-Related Adverse Events With Immunotherapies
May 03, 2024

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They d

Overcoming Barriers to Equitable Care in HNSCC
May 03, 2024

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They d

Current and Emerging Biomarkers of Response to Immunotherapeutic Regimens
May 03, 2024

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They d

The Role of Immunotherapy in the Treatment of Recurrent or Metastatic HNSCC: The Evidence
May 03, 2024

Host: Nabil F. Saba, MD, FACP Guest: Barbara Burtness, MD In this series, Drs. Nabil Saba and Barbara Burtness review best practices for the use of immune checkpoint therapies in the treatment of head and neck squamous cell carcinoma. They d

Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
May 03, 2024

Host: Craig M. McDonald, MD Guest: Crystal Proud, MD Guest: Aravindhan Veerapandiyan, MD There are ongoing clinical trials and approvals for new genetic and non-genetic therapies for Duchenne muscular dystrophy. Determining the most suit

ACC 2024: The PIONEER AF-PCI Trial
April 30, 2024

Host: Manesh R. Patel, MD This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on t

Limitations of the Current Therapeutics Used to Manage CIAS
April 30, 2024

Host: Philip D. Harvey, PhD Guest: Martin Strassnig, MD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy

Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
April 30, 2024

Host: Martin Strassnig, MD Guest: Philip D. Harvey, PhD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy

Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
April 30, 2024

Host: Philip D. Harvey, PhD Guest: Martin Strassnig, MD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy

Not All Therapy Needs to Be Swallowed or Injected: The Future of Digital Therapeutics to Alleviate the Negative Symptoms of Schizophrenia
April 30, 2024

Host: Martin Strassnig, MD Guest: Philip D. Harvey, PhD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy